首页> 外文期刊>Drugs & therapy perspectives: for rational drug selection and use >Management and outcome of Stevens–Johnson syndrome and toxic epidermal necrolysis in patients admitted to Kenyatta National Hospital
【24h】

Management and outcome of Stevens–Johnson syndrome and toxic epidermal necrolysis in patients admitted to Kenyatta National Hospital

机译:史蒂文斯 - 约翰逊综合征和有毒表皮性坏死的管理与结果,临近Kenyatta国家医院的患者

获取原文
获取原文并翻译 | 示例
           

摘要

Background Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous drug reactions requiring intensive care and protracted hospitalization. Local data on their characteristics, management and outcomes are minimal. Objectives Our objective was to identify the complications of SJS/TEN and the management strategies employed and the effect of these on patient mortality. Methods We conducted a retrospective cross-sectional study to determine the characteristics, management strategies and patient mortality associated with SJS/TEN in patients admitted to Kenyatta National Hospital from June 2006 to June 2016. Total population sampling was used to identify 115 patients with SJS/TEN. Data on disease complications, management strategies employed and mortality status as an outcome of therapy were extracted. Results Patients were predominantly managed using antimicrobials (16.4% of patients, 21.8% of whom received topical mupirocin). Fluid and electrolyte replacement, skin emolliation with liquid paraffin, temperature regulation and corticosteroids were used to treat 15.3, 13.4, 11.1 and 9.4% of patients, respectively. The mortality rate was 21.7%. Significantly ( p ?≤?0.05) higher mortality was associated with patients’ area of residence, disease subclass, disease severity score, hypokalaemia, dyspnoea, haematological disturbance, sepsis and dehydration. Conversely, use of total parenteral nutrition, anticoagulants for deep venous thrombosis prophylaxis and prolonged duration of therapy were associated with significantly ( p ?≤?0.001) lower mortality. Mortality was not associated with administration of corticosteroids or antibiotics. Independent predictors of mortality were hypokalaemia, dyspnoea, haematological disturbance and sepsis (all p ?≤?0.05). Conclusion The main management strategy used to treat SJS/TEN was antimicrobial prophylaxis, but this was not correlated with mortality. Mortality was high and was attributed to distant patient residence, severe disease and complications, suggesting that early recognition of these signs could avert mortality.
机译:背景技术史蒂文森 - 约翰逊综合征(SJ)和有毒表皮坏死(十)是需要密集护理和延长住院的严重皮肤药物反应。关于其特征,管理和结果的本地数据是最小的。目标我们的目标是确定SJS / TEN的并发症以及所雇用的管理策略以及对患者死亡率的影响。方法采取回顾性的横截面研究,以确定与2006年6月至2016年6月录取的克恩亚塔纳国家医院的患者与SJS / TEN相关的特征,管理策略和患者死亡率。总人口采样用于鉴定115名SJ /十。提取有关疾病并发症的数据,采用管理策略和作为治疗结果的死亡率状态。结果患者主要使用抗微生物(16.4%的患者,21.8%接受局部Mupirocin)。使用液体和电解质替代品,用液体石蜡,温度调节和皮质类固醇的皮肤润肺分别治疗15.3,13.4,11.1和9.4%的患者。死亡率为21.7%。显着(p?≤α.05)死亡率较高与患者的住所区域,疾病亚类,疾病严重程度评分,低钾血症,呼吸困难,血液神经干扰,败血症和脱水。相反,使用全肠外营养,抗凝血剂的深静脉血栓形成预防和长期治疗持续时间(p≤≤0.001)降低死亡率。死亡率与皮质类固醇或抗生素的给药无关。死亡率的独立预测因子是低钾血症,呼吸困难,血液神经干扰和败血症(所有P?≤≤0.05)。结论用于治疗SJS / T1的主要管理策略是抗微生物预防,但这与死亡率无关。死亡率高,归因于遥远的患者住宅,严重的疾病和并发症,这表明早期识别这些迹象可能会避免死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号